Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers.

Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Abstract Text:

    natasa bogavac-stanojevi?Natasa Bogavac-Stanojevi?,guenka ivanova petrovaGuenka Ivanova Petrova,zorana jeli?-ivanovi?Zorana Jeli?-Ivanovi?,lidija memonLidija Memon,slavica spasi?Slavica Spasi?,natasa bogavac-stanojevi?Natasa Bogavac-Stanojevi?,guenka ivanova petrovaGuenka Ivanova Petrova,zorana jeli?-ivanovi?Zorana Jeli?-Ivanovi?,lidija memonLidija Memon,slavica spasi?Slavica Spasi?,

    OBJECTIVES: The aim of our study was to determine the cost-effectiveness of coronary artery disease (CAD) diagnostic parameters in a clinical laboratory setting. DESIGN AND METHODS: The effectiveness of apolipoproteins, lipoproteins and high sensitivity C-reactive protein (hs-CRP) supplementary to Framingham scoring data within a CAD risk assessment procedure was established in 221 CAD patients and 289 controls. The total costs of diagnostic procedures were calculated and incremental cost-effectiveness analysis was applied. RESULTS: A diagnostic strategy employing Framingham calculation followed by apolipoprotein A-I (apoA-I) had the lowest cost per additional successfully diagnosed patient than the same strategy followed by hs-CRP in the low (2.63 vs. 24.47 euros) and intermediate-risk groups (2.96 vs. 122.85 euros). In the high-risk group the diagnostic strategy employing apoA-I saved 9.14 euros in comparison to the strategy employing hs-CRP. CONCLUSION: Cost-effectiveness analysis of different diagnostic markers results in improved identification of at-risk patients at a lower health cost for society.

    Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Publishing Authors By Initials

    n bogavac-stanojevi?N Bogavac-Stanojevi?,g ivanova petrovaG Ivanova Petrova,z jeli?-ivanovi?Z Jeli?-Ivanovi?,l memonL Memon,s spasi?S Spasi?,n bogavac-stanojevi?N Bogavac-Stanojevi?,g ivanova petrovaG Ivanova Petrova,z jeli?-ivanovi?Z Jeli?-Ivanovi?,l memonL Memon,s spasi?S Spasi?,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Clinical biochemistry

    VOLUME: 40

    Page Numbers: 1180-7

    Journal Abbreviation: Clin. Biochem.

    ISSN: 0009-9120

    DAY: 10

    MONTH: 08

    YEAR: 2007

    Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 133660

    Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers.

    AFFILIATION: Institute of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia. naca@pharmacy.bg.ac.yu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Clin Biochem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News